Engrail Therapeutics
Sue Maino is a seasoned clinical operations professional currently serving as Vice President of Clinical Operations at Engrail Therapeutics since April 2024. Prior experience includes leadership roles at NeuraWell Therapeutics as VP and Senior Director of Clinical Operations, as well as owning and consulting through Maino Group International and Maino Group Inc. Sue has a robust background in clinical project management across various biopharmaceutical contexts, including significant tenures at Intra-Cellular Therapies and Quintiles. Educational qualifications include a Bachelor of Arts in Psychology from the University of Notre Dame and a BSN in Registered Nursing from Oakland University.
This person is not in any offices
Engrail Therapeutics
Transforming the lives of patients with life-limiting diseases of the nervous system. Acquiring, developing and commercializing transformative medicines.